Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luigi Ciampo
Institution:
University of Salerno
Observed institution:
University of Salerno
ORCID:
0009-0005-3024-895X
Observed ORCID:
0009-0005-3024-895X
OpenAlex ID:
A5020029366
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
2023
·
Angelantonio Maglio
, Carolina Vitale
, et al.
·
International Journal of Molecular Sciences
·
72
PDF
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
2024
·
Claudia Crimi
, Santi Nolasco
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
53
PDF
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
2022
·
Alessandro Vatrella
, Angelantonio Maglio
, et al.
·
Biomedicines
·
44
PDF
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting
2023
·
Carolina Vitale
, Angelantonio Maglio
, et al.
·
Journal of Clinical Medicine
·
27
PDF
Show more works
View as search
Works count:
4
Citation count:
196
H-index:
4
I10-index:
4
Year
Topic
Type